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1. Introduction
Interaction of living organisms with their 
surrounding environment seeks to main-
tain a dynamic equilibrium that allows 
the organism’s survival and development. 
When confronted with unknown envi-
ronmental agents that may be potential 
threats (e.g., a pathogenic or damaging 
agent), organisms may behave in two ways. 
Either they react to the external challenge 
with a defensive response, or they change 
their physiological status as an adaptive 
response to their new conditions. This 
concept of dynamic equilibrium between 
defensive reaction and adaptive behavior 
is also relevant to the interpretation of 
nanotoxicological data. In this context, 
exposure of organisms to nanomaterials 
(NM) and the resulting response can be 
The interaction of a living organism with external foreign agents is a cen-
tral issue for its survival and adaptation to the environment. Nanosafety 
should be considered within this perspective, and it should be examined 
that how different organisms interact with engineered nanomaterials (NM) 
by either mounting a defensive response or by physiologically adapting to 
them. Herein, the interaction of NM with one of the major biological sys-
tems deputed to recognition of and response to foreign challenges, i.e., the 
immune system, is specifically addressed. The main focus is innate immunity, 
the only type of immunity in plants, invertebrates, and lower vertebrates, 
and that coexists with adaptive immunity in higher vertebrates. Because of 
their presence in the majority of eukaryotic living organisms, innate immune 
responses can be viewed in a comparative context. In the majority of cases, 
the interaction of NM with living organisms results in innate immune reac-
tions that eliminate the possible danger with mechanisms that do not lead 
to damage. While in some cases such interaction may lead to pathological 
consequences, in some other cases beneficial effects can be identified.
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interpreted as a response to a foreign dangerous agent. On 
this basis, rethinking nano-immunosafety would imply a more 
comprehensive, holistic organism-based evaluation of the inter-
action of engineered NM with the immune system, as one 
of the major biological systems that living organisms use for 
probing the external environment, sensing potential threats 
and mounting defensive or adaptive responses.
What does immunosafety mean in a nanoecotoxicological 
context? If an organism meets a NM, recognizes it as an alien 
substance (potential threat) and mounts a successful immune 
reaction (e.g., that eliminates it), does this represents in itself 
an adverse response? In our opinion it does not, because a suc-
cessful immune reaction is a physiological health-preserving 
defensive response to foreign agents and not alone a sign of 
toxicity. Thus, not only are the agents to which the organisms 
adapt (e.g., by actively preventing immune reaction) handled 
in a controlled way, but also those that are recognized as for-
eign may be directed to the appropriate cellular elimination 
system by an immune defensive response. A very important 
issue that we have to consider is that the real efficacy of a 
defensive immune reaction cannot be evaluated at the level of 
single cell types, as is the case in many in vitro toxicity assays. 
In fact, during a successful defensive immune reaction, which 
implies inflammation, many immune cells involved in the 
reaction may actually die, and some damage to the tissue may 
occur. However, the overall final outcome is the elimination of 
the threat, repair of the tissue damage and re-establishment of 
tissue integrity and function. Thus, the death of some cell types 
(such as polymorphonuclear phagocytes or monocytes) may not 
be alone a sign of immunotoxicity but of a normal homeostatic 
immune reaction. In this view, we should consider with critical 
attention the results obtained with single cell types in in vitro 
toxicological assays, as these may lead to incorrect assumption 
of systemic impacts when in an in vivo exposure, while such 
responses may actually be part of the normal immunological 
response to NM.
Although immune reactions may be part of a benign response 
to NM exposure, there are ways by which the presence of NM 
may affect immune responses in a fashion that could cause 
problems to the organism health. For example, could NM alter 
the normal defensive immune reaction to a threat, could the 
NM-induced metabolic or epigenetic changes in immune cells 
affect their capacity to mount an effective defensive response 
to a real danger, for instance an infection? Or could foreign 
or endogenous agents, when associated with NM, undergo 
structural changes thereby triggering an anomalous immune 
reaction, for instance become allergenic or triggering an auto-
immune reaction? Also, could NM, alone or associated with 
other agents, trigger a potentially pathological immune reaction, 
such as a chronic inflammatory response with associated tissue 
damage? Based on such considerations, we can therefore con-
sider NM as immunologically safe when they do not impair 
immune responses, and do not cause pathological immune 
reactions. Suitable assays, designed in a way that allows us to 
capture the relevant details of the nano-immune interaction, are 
required for adequately addressing these questions.
Nano-immunosafety, as in all toxicological approaches for 
any type of particulate and non-particulate agents, also depends 
on the nature of the exposure. NM concentration makes a 
difference, and the same NM can fail to induce an adverse 
immune response at a low dose, while triggering a strong reac-
tion at higher concentrations. Although this concept may sound 
obvious in toxicological studies, it is nonetheless important to 
bear this in mind when assessing the putative toxicity of NM. 
Also, the immune system of each organism can react/adapt dif-
ferently to the same NM at the same concentration. Thus, NM 
that elicit no adverse response at a specific concentration for 
immune cells (such as macrophages or dendritic cells (DC)) or 
for a given organism, may result in an adverse effect for other 
cells (such as epithelial cells) or other organisms at the same 
exposure level. This also is an obvious concept but it is worth 
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reiterating in the context of a potential adverse effect. Finally, 
we should consider that the ability of the immune system to 
cope with NM strongly depends on the health conditions of 
the organism, and that immature, aging or damaged/diseased 
organisms usually have impaired immune reactivity and may 
be less able to adequately cope with potential threats or, in gen-
eral, with foreign agents. Thus, we should be aware that it is 
impossible to define the immune response to a NM in a simple 
universal context, as its immunosafety will depend on the type 
of material, the exposure dose, route, and duration, the type of 
organism and the organism’s health conditions. The concept of 
“safe-by-design” NM is therefore a chimera, and what we can 
and should aim at is a nanotechnology that is “safer-by-design” 
in these different contexts.
Why do we think that nano-immunosafety studies should 
focus on innate immunity, although adaptive immunity is such 
an excellent and highly specific defense mechanism in man? 
The reason is that innate immunity is the earliest and most 
potent type of immune reaction, thus the first to be engaged 
in the encounter with foreign materials. Most importantly, 
innate immunity is the common type of immunity shared by 
the majority of living organisms, from plants to mammals, and 
is the only type of immunity of over 95% of living eukariotic 
species (except higher vertebrates from bony fish to mammals 
that also display adaptive immune mechanisms). The high 
evolutionary conservation of innate immunity has produced 
a number of defensive mechanisms that are maintained with 
little variations across evolution. This may imply that, in the 
recognition and response to NM, different organisms may 
engage similar mechanisms. Eventually, it must be recog-
nized that in the development of innate immune mechanisms 
a key role is played by the host interaction with bacteria. The 
immune system does not develop in germ-free animals, and 
this strongly suggests the interdependence and mutual coop-
eration of different living entities within an organism.
When assessing nano-immunosafety, we should consider the 
organism in its entirety (including its symbiotic bacteria) and 
also the environment in which it lives. In this review, we will 
try to address the interaction between NM and innate immu-
nity across evolution by taking in consideration all the issues 
stated above.
2. Nanomaterials and Innate Immune Effector Cells
2.1. Innate Immune Cells across Living Organisms
In different living organisms, there are cells and mechanisms 
that are able to recognize potential threats and react to them 
for defending and preserving the organism’s physical and func-
tional integrity.
Most interestingly, in plants there are no specialized immune 
cells. However, plants, as animals, can sense “danger” and react 
to unfavorable conditions.[1] Danger signals are mainly external 
factors such as pathogens, abiotic factors, and potentially also 
NM. As mentioned, plant defense does not depend on specific 
immune cells, as in principle all cells can sense threat. The 
response to challenge includes the release of preformed factors 
after cell wall damage, activation of danger receptors and the 
secretion of endogenous danger signals, the so-called phyto-
cytokines, that are able to alert adjacent cells.[2] The transport 
route for water and nutrients, through xylem and phloem, is 
used by agents such as small molecules, RNA, or peptides to 
achieve systemic activation of plant responses. NM can be also 
transported within the plant,[3] and therefore all plant tissues 
could potentially sense them. The extent by which NM can 
interfere with or be actively recognized by plants depends on 
the interaction interface, which is therefore a key element in 
determining uptake and subsequent reaction. Uptake of NM in 
plants is hindered by the cuticula in leaf tissue and the Cas-
parian strip, as well as the suberized endodermis in roots. Cell 
walls are also a barrier, which only some NM can pass. Thus, 
NM uptake by plants depends on many parameters, including 
plant species, tissue, NM size, properties, and application 
route. Uptake is reported for a number of nanoparticles (NP) 
in above-ground and underground tissues of specific plant spe-
cies, but it remains unpredictable, and no generalization can be 
made on the nature of NM that are taken up, the plant species 
and the conditions under which internalization occurs.[4]
Cells and tissues that form the interaction interface with 
NM in invertebrates represent the major animal recognition 
and defensive system in the many invertebrate phyla. They 
are worldwide distributed, in each environment, and are 
subjected to a wide range of threats even if their welfare is 
overlooked compared to the attention devoted to vertebrates. 
Invertebrate species are just as capable as vertebrates of expe-
riencing stress and damage, and possess an evolutionarily 
conserved immune system acting as a first line of defense 
against exogenous and endogenous threats to the host, such 
as pathogenic infection, tissue damage, or cancer. The inver-
tebrate immune system encompasses a number of innate 
defensive mechanisms, such as cellular responses involved in 
non-self recognition, phagocytosis, autophagy, cellular encap-
sulation, and nodulation.[5] The most frequently used inver-
tebrate model systems are those from the clade Protostomia 
(e.g., cnidarians). Some other new model systems, such as 
the sea urchin (Echinodermata), are members of the Deu-
terostomia, the same superphylum that includes vertebrates, 
and thus have mechanisms that are likely to be more closely 
related to those occurring in humans.
Unlike vertebrates, invertebrates lack classical antibody-
based adaptive immunity, and key molecular and cellular actors 
such as recombination-activating genes, B and T lymphocytes, 
except  for  some  exceptions, are totally absent.[6] Notably, some 
indications of alternative adaptive or anticipatory immune func-
tions and memory-like responses characterized by challenge-
specific long-term protection were found in a few insect and 
echinoderm species.[7,8] Recent findings blur traditional distinc-
tions between adaptive and innate immunity and emphasize 
that, throughout evolution, the immune system has used an 
unusually extensive selection of solutions to meet essentially 
comparable requirements for protection.[6] If the adaptive 
immune response is characterized by selective clonal gene 
rearrangements from a broad repertoire of antigen-specific 
receptors on T and B lymphocytes, the innate immune response 
is based mainly on different cell types recognizing invading 
pathogens and activating antimicrobial immune responses such 
as phagocytic cells, granulocytes, macrophages, and mast cells.[9]
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The use of invertebrate models for immunosafety investigation 
requires a knowledge on the behavior of cells mediating immunity 
in each selected species, the degree of specificity (specific, quasi-
specific, or nonspecific) and memory in their immune strategies, 
together with information on particle behavior in the environ-
mental medium in which animals live and the route of cell and 
organism exposure to NM. As a rule of thumb, the cells essen-
tially involved in the invertebrate cellular and humoral defenses 
are the circulating and sessile blood cells (currently termed 
hemocytes or celomocytes) as well as other cell types, including 
those residing in the fat body of insects, or in the hepatopancreas 
and gills in crustaceans.[10] Regardless of the adopted cell names 
of celomocytes and hemocytes, their defensive mechanisms are 
similar, and foreign material uptake and elimination is based on 
phagocytosis, enzyme activation (e.g., lysozyme), reactive oxygen 
species (ROS) formation, metabolic activation, and antimicrobial 
protein (AMP) production (e.g., defensins).[11]
In bivalve mollusks, hemocytes show both morphological 
and functional features resembling those of the mammalian 
monocyte/macrophage lineage.[12] As suspension feeders, 
bivalves have highly developed processes for the cellular inter-
nalization of nano- and microscale particles in the key bio-
logical functions of intracellular digestion and cell-mediated 
immunity. In this light, the hemocytes of different species 
(mussels, oysters, and clams) have been widely investigated as 
a possible target for the effects of NM.[13,14]
The coelomic fluid of the sea urchin Paracentrotus lividus 
carries three different freely circulating cells, phagocytes, ame-
bocytes, and vibratile cells, which are morphologically and 
likely functionally distinct.[15] In the human body, macrophages 
recognize size and shape of their targets, facilitating inter-
nalization via phagocytosis. The phagocytes of the sea urchin 
interact with NM (e.g., TiO2 NP) by internalizing them both 
in vivo and in vitro.[16–18] These cells have a dendritic-like mor-
phology and are the most abundant cell type present in the sea 
urchin body cavity fluid (>80%). Upon interaction with NM, sea 
urchin phagocytic cells potently respond with active phagocy-
tosis, becoming strongly adherent and metabolically active.[17,18]
Earthworm coelomocytes encompass two main subpopu-
lations, the amebocytes and the eleocytes, that differ for 
morphology, cytochemistry, and gene expression profile.[19] 
Eleocytes are large cells filled with a substantial amount of 
chloragosomes (large granules containing fluorophores). 
Although their main function is nutritional (e.g., storage of 
glycogen and lipids), they also produce a number of bioactive 
molecules.[11] Hyaline and granular amebocytes represent the 
main effector immunocytes and are specifically involved in 
a broad range of defense functions including phagocytosis, 
encapsulation, ROS production, and cytotoxicity,[11] corre-
sponding to the expression of many immune-related molecules 
found solely in amebocytes.[20] Cell viability is a meaningful 
immune marker in the earthworm, as it provides a general 
overview of the organism´s immune capacity. Immunocytes 
are reactive to a wide range of pollutants and may respond to 
NM in a distinct manner according to their immune reper-
toire. In pollutant-spiked soils the amebocytes/eleocytes ratio 
increases due to the higher mortality of eleocytes, which are 
more susceptible to pollutants than amebocytes. The most vis-
ible response difference is observed with metals, measured 
by neutral red uptake: after exposure, eleocytes started to die, 
while amebocytes showed enhanced phagocytosis.[21]
Arthropods, including insects and crustaceans, use a range 
of cellular and humoral immune defensive strategies to pro-
tect themselves from damage. The main cellular defense 
mechanisms are phagocytosis, nodule formation (nodulation), 
and encapsulation. Both nodule formation and encapsulation 
are responsible for the isolation and walling off of invading 
microbes and macroparasites.[22] In insects, there are circulating 
blood cells, sessile hemocytes, and various other cell types like 
cells in fat body. Several types of hemocytes were described in 
insects with the majority of species possessing only a few of 
them.[23] For example, Drosophila hemocytes include three cell 
types:[24] plasmatocytes, which are involved in phagocytosis and 
release of immune effector and signaling molecules; crystal 
cells, which contain pro-phenoloxidase (PO) and other proteases 
of the pro-PO activating system;[25] and lamellocytes, which are 
rare in naïve animals but differentiate during infection and 
participate to encapsulation. Within the hemocoel of terrestrial 
isopods (such as Porcellio scaber), nongranular or hyaline hemo-
cytes are mainly responsible for phagocytosis.[26] Semigranular 
cells also show some phagocytic ability but are apparently more 
involved in encapsulation and nodulation. Granular cells are 
predominately connected with the PO system[27] and, along 
with semigranular cells, are thought to produce AMP and also 
contribute to antioxidant defense.[28] In crustaceans, there are 
reports that shrimp immune parameters (i.e., total hemocyte 
count, respiratory bursts, PO, and superoxide dismutase (SOD) 
activity) were significantly affected by exposure or ingestion 
of ZnO NP.[29] In a recent study on larvae, pupae, and adults 
of Tenebrio molitor, transmigration of nanodiamonds through 
the insect cuticle was followed by inhibition of cellular and 
humoral immune responses, presence of phagocytosed nano-
diamond aggregates mainly in hemocytes, and also in fat body 
cells, but not in Malpighian tubule cells.[30]
Mammalian exposure to NM occurs at epithelial barriers 
such as the epidermis, at mucosal sites if inhaled or ingested, 
or directly in circulation, as in the case of nanomedical appli-
cations. Generally, NM do not cross the intact epidermal bar-
rier,[31] and therefore the contact with immune cells can more 
easily occur upon mucosal or intravenous exposure. Cells of the 
innate immune system can be abundantly found in the mucosal 
tissues and in circulation, have the task of recognizing foreign 
objects such as NM, and initiate an appropriate response. As 
already mentioned, the response can be adaptation/lack of reac-
tion (meaning that the foreign objects are considered harmless) 
or a defensive response. A successful response of these cells 
will lead to sequestration and elimination or destruction of 
potential threats, including NM, while insufficient or overactive 
responses may lead to infection and tissue damage.
In mammals, cells of the innate immune system are present 
in the blood and in all body tissues. While many functions, 
such as pattern recognition, are conserved across innate cells, 
each type contains specializations that benefit host defense. The 
most abundant of innate cells are the short-lived phagocytic 
and inflammatory cells called neutrophilic polymorphonuclear 
leukocytes or neutrophils, which comprise between 50% and 
70% of the white blood cells found in circulation. Their primary 
function is phagocytosis and destruction of foreign objects, 
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and they enter challenged tissues in large numbers following 
a set of events known as the neutrophil recruitment cascade.[32] 
Once in the tissue, they are able to engulf objects for phagocytic 
destruction, release factors and enzymes aimed at degrada-
tion of invaders, and release the so-called neutrophil extracel-
lular traps (NET) that can capture and degrade objects in the 
surrounding environment.[33] Eosinophils are short-lived cells 
mainly residing in tissues, involved in bacterial and parasite 
clearance. They function through release of granules containing 
different defensive molecules such as RNAses, peroxidases 
and soluble mediators (cytokines, chemokines, and growth fac-
tors). Eosinophils are additionally known to be involved in the 
pathogenesis of allergies and asthma.[34] Mast cells are large and 
probably long-lived tissue-resident cells with several functions. 
Among them, they are innate effector cells involved in allergic 
reactions and inflammation but also in anti-inflammatory activi-
ties, upon activation and subsequent release of chemical media-
tors by degranulation.[35] Within their defensive functions, mast 
cells are involved in pathogen clearance in many bacterial, viral 
and parasitic infections, upon release of proteases, AMP, and 
ROS production. Indeed, their primary evolutionarily conserved 
role seems to be inflammation and pathogen killing, with a spe-
cific capacity of toxin and venom detoxification. Innate lymphoid 
cells (ILC) are a heterogeneous group of innate cells of lymphoid 
origin classified into three subtypes according to their pheno-
types, functions and cytokine expression profiles. ILC1 includes 
the classical natural killer cells, mainly secrete IFN-γ and can 
induce T helper 1 cell activation. ILC2, also known as natural 
helper cells or nuocytes, secrete a number of interleukins (IL-4, 
IL-5, IL-9, and IL-13) in response to parasitic infections, and are 
involved in T helper 2 responses, including allergic reactions. 
ILC3 produces IL-22 and or IL-17 and are involved in the activa-
tion of T helper 17 cells. As all innate cells, ILC are mainly acti-
vated by stress signals, the cytokine milieu of the surrounding 
tissue and microbial compounds.[36]
Eventually, the mammalian innate immune system is highly 
dependent on the multifunctional action of monocytes, mac-
rophages and DC. Monocytes are phagocytic cells found in 
the blood, comprising ≈10% of the circulating white blood cell 
population. Upon tissue damage, monocytes are recruited to 
the tissue site and act as effective killer cells and initiators of 
a more general defensive inflammatory reaction. Most of the 
inflammatory monocytes that enter a tissue probably die during 
the local inflammatory reaction, but it is possible that some of 
them survive and differentiate into macrophages or DC within 
the healing tissue. Macrophages are the tissue-resident mono-
nuclear phagocytes, mostly self-renewing tissue cells to which 
differentiated monocytes may contribute in different propor-
tions (depending on the tissue).[37] Macrophages are mostly 
scavenging cells that keep the tissue clean by eliminating 
senescent, dead or anomalous cells and denatured proteins. 
Macrophages are also sentinel cells that perceive foreign agents 
(mostly invading microorganisms but also NM), can phagocy-
tose and engulf them for destruction within a phagolysosome, 
or sequester them for eventual elimination. Notably, mac-
rophages are poor inflammatory effector cells but, if required, 
they can initiate a defensive response by producing factors that 
recruit and activate circulating effectors (such as neutrophils 
and monocytes). Eventually, at the end of an inflammatory 
reaction macrophages participate to resolution of inflamma-
tion and tissue remodeling, thereby re-establishing the healthy 
physical and functional status of the tissue.[38] DC are similar 
to monocytes and macrophages in their phenotype and func-
tions, although they are poorly phagocytic, and are specialized 
in antigen presentation (a feature shared by other cell types 
although less efficiently). DC are present in the circulation and 
in tissues (immature DC), and are activated upon interaction 
with foreign objects (mature DC), becoming able to efficiently 
present antigens.[39]
In conclusion, while in plants no specialized immune cells 
exist but all cells can sense and react to NM, in animals (from 
invertebrates to mammals) phagocytic cells are the major 
effector of the innate immune defensive responses (Figure 1). 
These cells may adopt different morphologies in different 
microenvironmental conditions and can encompass subpopula-
tions with different names and more specialized roles in each 
organism, but they all have in common the capacity of rap-
idly adapting to the presence of foreign materials by uptaking 
and degrading/destroying them either directly or through the 
release of effector molecules. The modes of sensing and rec-
ognition of foreign agents determines the type of reaction by 
immune cells. A depiction of the interaction and uptake of NM 
with innate immune cells is presented in Figure 2.
2.2. Interaction of Nanomaterials with Innate Cells Depends 
on the Microenvironment
The ability of NM to induce any type of reaction in immune 
cells strongly depends upon the previous interaction of 
microenvironmental factors with the highly reactive NM sur-
faces. NM entry in a body implies a rapid interaction with 
body fluids. Biomolecules adsorb to the surface and create 
a “biomolecular corona.” Thus, NM sensing is based on the 
biomolecular corona composition, and its particular spacing 
and structure, which depends both on the NM chemistry and 
size and on the biological tissue/fluid in which NM are pre-
sent.[40] The corona can be a complex structure, sometimes 
20–30  nm thick, consisting of soft and hard layers (soft and 
hard corona), based on the affinity of the NM–biomolecule 
interactions. Since the corona is composed by self-proteins 
and other self-molecules, these can mask the NM surface 
and prevent immune recognition. However, the interaction 
with the NM surface can alter the 3D structure and folding of 
proteins, thereby making them signals for non-inflammatory 
elimination by phagocytes or triggers for a defensive innate/
inflammatory response.[41] Opsonization with complement 
components, one of the most efficient innate defensive 
mechanisms against bacteria, can occur upon adsorption of 
complement proteins in the NM biomolecular corona. Com-
plement components can promote clearance by phagocytes 
through complement receptors, or trigger inflammation by 
activating the complement cascade.
Evidence for the implications of NM biocorona in immune 
recognition and response is also emerging in non-mammalian 
vertebrate and invertebrate models. In zebrafish blood plasma, 
sex-specific coronas were identified around SiO2 NP,[42] with the 
prevailing contribution of vitellogenins conferring a “female” 
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biological identity to the NM. Moreover, zebrafish lymphoid and 
myeloid blood cells preferentially accumulated those NP with a 
female corona profile. The capacity of leukocytes to remove such 
NP–protein complexes from the bloodstream would prevent spe-
cific targeting of vitellogenin-coated NP to developing oocytes, 
and possible downstream consequences on reproduction.[42]
NM can be coated with proteins and other molecules also 
in biological fluids of invertebrates. In earthworms, the bioco-
rona formed around Ag NP contains a predominant protein, 
lysenin, that ultimately triggers higher uptake by immune 
cells.[43] By analyzing gene transcription kinetics upon in vivo 
exposure to Ag NP, the transcription of lysenin was, after tran-
sient induction, gradually suppressed over time, with induction 
of a new secretome, suggesting a reshuffling of the NP bioco-
rona that will change the interaction with immune cells.[44] In 
the marine mussel Mytilus, the complement component C1q 
and Cu,Zn-SOD represent the single protein types present in 
the biocorona that forms, upon in vitro interaction with mussel 
biological fluid, on different types of NM with positive (PS-NH2 
NP) or negative (CeO and TiO2 NP) charge, respectively.[45] 
The formation of a distinct corona increased or decreased the 
immunotoxicity of either type of NM for hemocytes.
In the celomic fluid of the sea urchin P. lividus, the bioco-
rona formed around PS-NH2 was dominated by the toposome 
precursor protein. Such biocorona promoted Ca2+-dependent 
recognition by phagocytes, leading to uptake followed by tox-
icity.[46] In contrast, the main constituents of the biocorona on 
the surface of TiO2 NP exposed to the supernatant of cultured 
sea urchin immune cells were identified as a subset of adhe-
sion and cytoskeletal proteins. Upon coating with these pro-
teins, TiO2 NP aggregated on the outer cell surface of phago-
cytes and were then internalized within well-organized vesicles 
without eliciting harmful effects.[16]
Overall, data so far obtained in invertebrates indicate that, 
in each species, NM can be coated by different and peculiar 
proteins, which makes the biological implications less straight-
forward.[45] In addition, the results obtained in marine inverte-
brates suggest that the net surface charge retained by different 
NM in biological fluids is an important factor in the formation 
of a stable surface coating and for the consequent interaction 
with immune cells.
It should be noted that a corona can form on NM surface 
even before entry into an organism, by surface adsorption of 
environmental agents (such as bacterial components or aller-
gens). As in the case of the biomolecular corona mentioned 
above, the composition and steric/architectural features of 
the corona determines the subsequent interaction with living 
organisms. We should underline the fact that no naked NM can 
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Figure 1. Innate immune cells across living species. SEM images of A) a hemocyte of the mussel Mytilus galloprovincialis, B) a hemocyte of the earth-
worm Eisenia andrei, C) a phagocyte of the sea urchin Paracentrotus lividus, and D) a hemocyte of the woodlouse Porcellio scaber. E) TEM image of a 
human monocyte-derived dendritic cell (after in vitro differentiation for 6 days with GM-CSF and IL-4). F) SEM image of a human blood monocyte 
after 7 days of culture on a collagen matrix. G) TEM image of a human monocyte-derived macrophage, differentiated for 7 days in culture with M-CSF. 
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be found in our environment, and therefore the biological sys-
tems interact with “hybrid” NM that include environmentally 
borne non-characterized molecules on their surface.
2.3. Innate Sensing Mechanisms in the Recognition and Uptake 
of Nanomaterials
It is hypothesized that innate cells may sense NM upon inter-
action with surface receptors, mainly through typical innate 
immune pattern recognition receptors (PRR).
Plant PRR are similar to animal toll-like receptors (TLR), 
and can recognize microbe- or pathogen-associated molecular 
patterns (M/PAMP), thereby triggering defense responses that 
include ROS production, MAP kinase (MAPK) activation, and 
induction of defense genes, as well as immediate responses 
such as phytohormone release and callose deposition to 
strengthen the cell walls. The sum of these responses leads to 
enhanced resistance of the plant to invading pathogens, a phe-
nomenon known as pattern triggered immunity (PTI). Some 
pathogens can suppress PTI by injecting virulence factors into 
the plant cells that are negatively affecting PTI signaling com-
ponents, leading to enhance susceptibility of the plant. Plants 
can recognize some of these virulence factors by NOD-like 
intracellular receptors (NLR) that can trigger a fast defense 
response that includes ROS production and MAPK activation, 
but that can also lead to a hypersensitive response resulting in 
cell death of the infected plant parts and restricting nutrition to 
the invading pathogen.[47] If and how plants use these mecha-
nisms to sense and react to NM is poorly known at present.
In invertebrates, the innate defense mechanisms also 
depend on sensing foreign material by several classes of 
immune receptors, which bind PAMP and damage-associated 
molecular patterns (DAMP) and activate rapid innate defensive 
reactions. As in plants, both cell surface receptors and intracel-
lular sensing mechanisms can identify PAMP and initiate the 
innate immune response.[48] Echinoderms,[49] amphioxus[50] 
and, independently, also mussels[51] and sponges[52] have an 
expanded repertoire of PRR that include the intracellular NLR 
and the transmembrane TLR, while arthropods, nematodes, 
earthworms,[53,54] and tunicates have a more limited repertoire, 
all resulting from independent but combinatorially constrained 
evolution of domain architectures.[55] The invertebrate immune 
cells also express a wide range of inducible genes coding for 
extracellular recognition proteins, including lectins, pepti-
doglycan-recognition proteins, lipopolysaccharide (LPS) and 
β1,3-glucan-binding proteins, and fibrinogen-related proteins 
(FREP).[56–59]
Despite the presence of PRR and their clear role in pathogen 
recognition and immune reaction to threats, recognition of NM 
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Figure 2. NM uptake by innate immune cells across living species. A) Representative TEM image of a hyaline hemocyte of the earthworm Eisenia andrei 
showing internalized CuO NP (red arrows) after in vitro exposure (100 µg mL−1 CuO NP, diameter 5–15 nm) for 2 h. B) TEM image of a phagocyte of 
the sea urchin Paracentrotus lividus showing internalized TiO2 NP (red arrow) following in vitro exposure (1 µg mL−1 TiO2 NP, diameter 10–65 nm) for 
24 h. C) TEM image of a human monocyte-derived macrophage exposed to Au NP (20 µg mL−1, 50 nm diameter) in vitro for 24 h. The white-framed 
area is magnified and displayed in (D), where red arrows indicate some of the internalized Au NP.
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by celomocytes through PRR sensing has been reported only 
in the case of recognition and uptake of TiO2 NP by sea urchin 
phagocytes through TLR4.[18] Otherwise, these is no evidence of 
a direct receptor activation by NM with subsequent inflamma-
tory activation.
In vertebrates, both TLR and NLR are present, generally in 
a smaller number than in invertebrates (possibly because of 
the presence in higher vertebrates of adaptive immunity).[55] 
On mammalian innate cells additional PRR include scavenger 
receptors (SR) and C-type lectin receptors, which can sense dif-
ferent types of microbe-associated molecular pattern (MAMP), 
PAMP, and DAMP, allowing cells to react appropriately to 
changes in their tissue conditions.[60,61] Upon activation, PRR 
initiate a series of intracellular signals that lead to an immune 
response intended to eliminate the threat and restore tissue 
condition. Several NM have been reported as able to activate the 
NLRP3 inflammasome,[62–66] thereby inducing caspase-1 activa-
tion and the production of inflammatory IL-1β. Mechanisms of 
inflammasome activation by NM include induction of K+ efflux 
and ROS generation and lysosomal membrane destabilization. 
Caspase-1 activation and pulmonary inflammation by silica 
particles has been shown depending on the presence of the 
scavenger receptor SR-B1.[67]
Generally, NM seem readily taken up by phagocytic cells. In 
some cases it has been shown that PRR such as SR and TLR 
participate to the uptake,[68,69] and it is important to note that 
the presence and characteristics of the biomolecular corona 
can dictate the type of interaction of NM with SR or other 
innate receptors (e.g., complement receptors for complement-
opsonized NM). After interaction with the cell membrane, NM 
uptake also depends upon factors such as shape, size, surface 
charge and surface chemistry. It was shown that particles with 
a diameter ≤0.5 µm as well as rod/fiber-shaped NM were pref-
erentially taken up by DC compared to larger particles or those 
with cubic or spherical shape.[70–73] Smaller NM (≤500  nm) 
are mainly internalized via pino- or micro-pinocytosis and 
via clathrin- or caveolin-mediated endocytosis, while NM of 
>500  nm are usually taken up by phagocytosis.[74–76] Thus, it 
appears that mechanical forces, as well as opsonizing proteins 
interacting with the various receptors, are responsible for the 
majority of NM endocytic uptake, with a major role for NM size 
and shape in determining the type of uptake mechanism.
These NM internalized via endocytosis are encapsulated 
into early endosomes that then fuse with lysosomes, to form 
endolysosomes. Elimination of endocytosed particles may be 
achieved with lysosomal enzymes (if the NM are sensitive to 
them) or by autophagic processes.[77–79] However, intracellular 
degradation of several NM, for instance gold or tattoo pigment 
particles, is not readily achieved. Consequently, many particles 
that are engulfed by cells may remain as such for prolonged 
periods without inducing toxic effects, or can be passed from 
macrophage to macrophage during time or upon cell death[74,80] 
Innate immune cells can also capture and degrade NM without 
engulfing them. Indeed, neutrophils, eosinophils, and mast cells 
can react to the interaction with NM with degranulation and 
release of proteases and other enzymes. Several studies have 
shown that neutrophil and eosinophil peroxidases (EPO) can 
degrade both multi-wall and single-wall carbon nanotubes.[81,82]
Another mechanism of particle capture and clearance that 
does not imply their internalization is the formation of extracel-
lular traps (ET).[83] Upon challenge resulting in cell death, cells 
release a net of chromatin fibers, which are used to immobilize 
extracellular particles, such as pathogens or non-self objects. 
The innate cells that can form ET include eosinophils, mono-
cytes, macrophages, neutrophils, and mast cells.[34,84] This pro-
cess is evolutionarily conserved, and ET have been described 
also in plants and invertebrates.[85,86] ET are often coupled with 
local release of ROS and enzyme-containing intracellular gran-
ules, which contribute to trapped particle degradation. Indeed, 
this mechanism acts efficiently also for NM, as shown in a 
study describing the peroxidase-dependent extracellular deg-
radation of single-walled carbon nanotubes trapped in NET.[87] 
NM can trigger ET formation in vivo possibly through lyso-
somal leakage and ROS production.[88,89]
Based on these observations, we can generally conclude that 
NM are sensed by innate cells through different receptors/
mechanisms and either internalized and tagged for elimination, 
or can induce cell activation (mainly associated to cell death) 
that leads to ET formation and eventual particle handling. 
Table  1 summarizes the reported examples of NM–innate cell 
interaction across species and their functional consequences.
3. Nanomaterials and Activation of Innate 
Immune Genes/Factors
In addition to, and as part of, cell-based mechanisms of sensing 
and reaction to external challenges, a wide array of soluble 
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Table 1. Cells and tissues interacting with NM across species.
Species Cell/tissue Cell function NM type Refs.
Zea mays L. (plant) Xylem Transport tissue in vascular plants CuO [3]
Mytilus galloprovincialis (mollusc) Hemocytes Phagocytosis, opsonization, cytotoxicity, inflammation, humoral response, 
ROS and NO production
TiO2
PS-NH2
CeO NP
[14, 45]
Eisenia fetida (earthworm) Amoebocytes eleocytes Phagocytosis, opsonization, cytotoxicity, inflammation, humoral response, 
ROS and NO production, graft rejection
Ag [14, 44]
Paracentrotus lividus (sea urchin) Phagocytes Phagocytosis, opsonization, clotting, cytotoxicity, inflammation, humoral 
response, graft rejection, ROS and NO production, clearance
TiO2 [16–18]
Penaeus semisulcatus (shrimp) Hemocytes Encapsulation, cytotoxicity, PO activity ZnO [29]
Homo sapiens Macrophages Phagocytosis, clearance, inflammation TiO2 [41]
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molecules are produced that either directly exert defensive func-
tions or communicate with surrounding tissues for mounting a 
defensive response. Figure  3 depicts the main molecules and 
pathways involved in the immune defensive reactions across 
species.
Upon cell damage or PRR activation, plants can release pre-
formed factors and phytocytokines, which function as endog-
enous danger signals that alert adjacent cells.[2] Most of the 
defensive factors produced by plants are soluble molecules that 
reach all plant tissues using the same transport route as water 
and nutrients. Depending on the type of pathogen, plants react 
by producing ROS and phytohormones such as salicylic acid, 
jasmonic acid, and ethylene.[90] NM are reported to activate 
some of these molecular defense responses, mainly ROS pro-
duction and gene activation, suggesting that responses to NM 
may share similarities with immune responses.[91] Interestingly, 
recent transcriptomic analysis in Arabidopsis thaliana revealed 
that exposure to different types of NP (e.g., ZnO, fullerene soot, 
or TiO2) repressed a significant number of genes involved in 
phosphate starvation, pathogen and stress responses, with pos-
sible negative effects on plant root development and defense 
mechanisms. A recent systems biology approach, including 
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Figure 3. Innate immune molecules and signaling across living species. Upper panels: comparative examples of evolutionary conserved innate sign-
aling in plants (Arabidopsis), insects (Drosophila), sea urchins, and mammals. Signaling cascades initiate when pattern recognition receptors (PRR) on 
the cell membrane recognize specific pathogen-associated pattern (PAMP). Signal is transduced within the cytosol by a set of signaling proteins (mainly 
protein kinases), which in turn activate evolutionary conserved transcription factors that will orchestrate transcription of inflammatory related genes. 
Consequently, each organism produces a panel of soluble molecules (pathogenesis-related proteins, antimicrobial peptides, cytokines, and others) that 
contribute to coping with different foreign agents. Lower panels: comparative list of PRR and soluble molecules (pathogenesis-related proteins (PR), 
antimicrobial peptides (AMP), and cytokines) known in plants (Arabidopsis), insects (Drosophila), sea urchins, and mammals. Artwork by Andi Alijagic.
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omics data from tobacco, rice, rocket salad, wheat, and kidney 
beans, confirmed that metal NM provoke a generalized stress 
response, with the prevalence of oxidative stress compo-
nents.[92,93] However, a general view on NM-induced immune 
responses is difficult, as contradictory results have been 
obtained by different groups, possibly due to different experi-
mental conditions.
Invertebrate immune cells (hemocytes and celomocytes) are 
responsible for immune reactions through phagocytosis and 
the production of a number of cytotoxic factors, such as hydro-
lytic enzymes, AMP, ROS, and nitric oxide (NO).[11,12,14,94,95] 
Upon exposure to TiO2 NP, earthworm engulf NP by phagocy-
tosis, and simultaneously modify mRNA expression of immune 
proteins and metallothioneins, thereby affecting the molecular 
response of immune and detoxification systems.[96] Immune 
cells also express many inducible immune-related genes that 
are able to bind microbial patterns. Some of these are mem-
brane proteins involved in recognition, e.g., lectins and lectin-
like molecules (see previous section), while others are released 
as soluble proteins, such as FREP and AMP.[11,97]
In the marine mussel Mytilus, hemocyte functional param-
eters and transcription of different immune-related genes are 
affected by exposure to different NM types with a high degree 
of specificity.[13,98] Echinoderm gene sequencing reports over 
1000 immune genes falling into the innate immunity area,[55] 
and exposure of P. lividus to NM induces selective changes in 
immunological pathways and molecules.[99] As an example, 
exposing P. lividus to TiO2 NP activates suppressive mecha-
nisms by down-regulating the expression of genes encoding 
immune-related and apoptotic proteins (e.g., NFκB, FGFR2, 
JUN, FAS, VEGFR, and Casp8); elicits metabolic rewiring by 
boosting the immune cell antioxidant activity (e.g., pentose 
phosphate, cysteine-methionine, glycine-serine metabolism 
pathways); and restores homeostasis by keeping at physiolog-
ical levels some key immune-related proteins (e.g., TLR4, IL-6, 
MAPK, heat shock protein 70 (HSP70)).[17]
The earthworm celomic fluid also contains various antimi-
crobial factors or peptides, such as lysozyme and lumbricin/
lumbricin-related protein, and hemolytic molecules such as 
fetidin and lysenins. In Eisenia earthworms, lysenin turned out 
as a key protein in the earthworm secretome upon interaction 
with Ag NP, and it is possibly involved in opsonization-induced 
cellular interaction.[43] The supplementation of culture medium 
with celomic fluid supports celomocyte survival during in vitro 
culture. Such protein-rich environment, present both in the 
earthworm body and in the supplemented culture medium, 
leads to the formation of a biomolecular corona on the NM sur-
face during exposure. The biomolecular corona can function as 
opsonin that promotes phagocytosis. Indeed, earthworms can 
efficiently opsonize microbial particles by means of the soluble 
form of the receptor protein celomic cytolytic factor (CCF).[11,100] 
As membrane protein CCF participates in the activation of 
the pro-PO cascade, while its soluble form has opsonizing 
capacity.[101] Upon incubation of synthetic NM (HEMA particles) 
with celomic fluid, CCF was adsorbed onto the particle surface 
in a manner that was recognizable by CCF-specific monoclonal 
antibodies (i.e., surface-adsorbed CCF retained its native confor-
mation). This adhesion capability of CCF is an early example of 
pattern recognition-independent opsonization of non-biological 
particles.[102] One of the mechanisms by which NM may provoke 
cell toxicity is ROS generation. Oxidative stress is usually moni-
tored by assessing lipid peroxidation and measuring antioxidant 
enzymes.[103] Although exposing celomocytes to metallic NP can 
lead to ROS production,[104] it is still controversial whether such 
effect can be ascribed to NP or to released metal ions. Celomo-
cytes exposed to metal-based NP (Ag and carbon) show modu-
lated expression of oxidative stress genes and induction of ROS 
production.[105–107] The antioxidant enzyme catalase is more 
effective in ROS neutralization than superoxide dismutase in 
earthworms.[108] Upon catalase down-regulation, the accumula-
tion of H2O2 was shown to accelerate NP dissolution.[109]
In arthropods (including crustaceans), lectins from the 
hemolymph are important in immune recognition and phago-
cytosis. A major defense molecule in the immune response 
of crustaceans is the conserved Cu-containing enzyme PO. A 
number of pattern-recognition proteins (such as PGBP, LGBP, 
and BGBP) participate in immune defense by recognizing 
pathogen-associated carbohydrate-containing molecules, i.e., 
peptidoglycans, lipopolysaccharides, and β-glucans.[110] In 
insects, the tracheae, epidermis, gonads, and gut epithelium 
are involved in release of PO and AMP and in the production of 
ROS.[111] As in many other invertebrates, melanin synthesis is a 
central mechanism of innate immunity and a major response 
to a variety of immune challenges.[112–116] Part of the melanin 
synthesis pathway is catalyzed by the enzyme PO. The PO cas-
cade produces melanin, and also induces multiple potent bioac-
tive agents, such as peroxinectin and ROS, that aid in phago-
cytosis and cell adhesion. Proper PO modulation is crucial to 
ensure survival of the organism. The majority of invertebrates 
activate the PO cascade from the pro-PO enzyme upon recog-
nition of foreign matter.[117] However, in a limited number of 
Crustacea, including P. scaber, the production of melanin is not 
initiated by pro-PO, and it has been suggested that hemocyanin, 
the oxygen transporter in isopod hemolymph, is responsible for 
initiating the cascade by undergoing a conformational change 
upon interaction with non-self material.[118]
Reactive nitrogen species are chemically reactive species that 
include NO, and are produced through normal metabolism, 
after an injury, during infections and disease and in response 
to environmental pollutants and radiation. NO is known to 
modulate many biological processes including inflammation 
and cytotoxicity.[119] In crayfish, the hemocyte-derived NO was 
able to promote hemocyte-bacterial adhesion and increase the 
hemocyte bactericidal activity.[120]
AMP are another major component of the invertebrate defen-
sive system. They are small cationic, amphipathic molecules 
effective against Gram-positive and Gram-negative bacteria, 
yeasts, fungi, and some protozoa and enveloped viruses. AMP 
are found in the isopod hemolymph, function by disrupting the 
target cell membrane integrity via destabilization or pore for-
mation, and there is some evidence that they may be translo-
cated into the microorganisms’ cytoplasm where upon they can 
interact with specific intracellular targets to cause cell death.[121]
In vertebrates, and more specifically in mammals, it is 
known that several types of NM (e.g., carbon, silica, polysty-
rene, and latex NM) can interfere with the immune system, 
inducing oxidative stress, complement activation and release of 
soluble mediators such as cytokines, chemokines and growth 
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factors. Although an immunomodulatory effect has been 
shown for several types of NM, the extent of activation of the 
immune response is specific for every type of object, from 
minimal (Au NM) to substantial (carbon nanotubes). When 
NM are used as biomedical products, they are often actively 
injected in the bloodstream where they  encounter a complex 
environment of plasma proteins and immune cells. NM can be 
sensed and come in contact with monocytes, platelets, polymor-
phonuclear leukocytes, and DC and subsequently with tissue 
resident phagocytes. The encounter between NM and immune 
cells/factors at the site of injection can lead to several reactions, 
which could ultimately result in the complete clearance of the 
NM. Hemolysis, thrombogenicity, and complement activation 
are the main processes considered relevant, from a toxicological 
point of view, when NM are injected in the bloodstream.[122] For 
example, it has been reported that Ag NP at high concentra-
tions can induce hemolysis and affect lymphocyte viability in 
human and rat blood in vitro, while unable to activate com-
plement and induce platelet aggregation, and also increase 
sensitivity to thrombogenic factors in vivo in the rat.[123,124] 
The effects obtained at very high doses used in these studies 
do not appear at lower concentrations. Depending on their 
physico-chemical properties, NM may trigger the activation of 
the complement system, which is crucial for the rapid detec-
tion and elimination of circulating particles and pathogens by 
phagocytic cells. The complement system acts with three main 
mechanisms. The first is the coating of pathogens/foreign 
objects with proteins acting as opsonins (e.g., the complement 
components C1q or C3b) that can be recognized by specific 
receptors on the surface of phagocytic cells thereby promoting 
clearance via phagocytosis. The second is the production of 
chemotactic peptides (e.g., the complement component C5a) 
for recruiting monocytes and neutrophils to the site of reaction. 
Finally, the third mechanism is the formation of the membrane 
attach complex on the microorganism surface that leads to lysis 
of the pathogen.[125,126] Several studies reported the capacity 
of NM to activate the complement system, with NM surface 
charge playing a most prominent role. Charged NM (e.g., lipid 
and polycation-based NP) could easily bind human serum com-
plement, compared to their neutral PEGylated counterparts.[127] 
Surface characteristics also are predictive of NM–complement 
interactions. It has been shown that dextran coating in loop 
configuration increases cleavage of C3 into C3a and C3b upon 
incubation in human serum compared to polymers in brush 
formation,[128] and that the switch of polymer configuration is 
associated with a shift from the classical to the lectin comple-
ment pathway.[129] Although complement activation has been 
claimed as an important safety issue in relation to medicinal 
NM, it seems that a major role is instead played by activation 
of innate cells.[130] This stresses the need of examine in depth 
the complex interrelationships among innate immune mecha-
nisms activated by exposure to NM, in particular in the design 
and production of nano-medicaments.
As in invertebrates, NM can also induce ROS production and 
oxidative stress in mammalian cells. Although ROS are natural 
byproducts of cellular metabolism with an important role in cell 
survival, death, differentiation, signaling, and inflammation, an 
imbalance in their generation and neutralization can result in 
oxidative damage, leading to cell death. Several NM, such as 
TiO2, ZnO, CeO2, Mn3O4, and Ag NP, have been reported able 
to induce oxidative stress signaling cascades in mammalian 
cells.[131,132] During an inflammatory reaction, innate immune 
cells produce matrix metalloproteinases (MMP), which are fac-
tors involved in the degradation and remodeling of the extra-
cellular matrix during wound healing. Recently it has been 
reported that different NM (Ag, Au, Zn, and carbon-based 
NP) can regulate the synthesis of some MMP,[133,134] although 
the variability of study models and of NM used does not yet 
allow full understanding. Overall, the possibility of using NM 
to modulate/control the immune cell activation and their ROS 
and MMP production opens promising  perspectives for new 
therapeutic approaches.
Also in the case of mammals, AMP are produced for con-
trolling the interaction with bacteria. AMP, which include 
defensins and cathelicidins, are involved in maintaining 
healthy commensal gastro-intestinal flora and in bacterial clear-
ance, with functions ranging from direct bactericidal activity 
to initiation of innate immune responses.[135] Experimental 
evidence shows that different types of NM can promote and 
amplify the antibacterial capacity of AMP, as in the case of the 
synergistic effect of Ag NP with the bacterial AMP polymyxin 
B, likely caused by the polymyxin B-driven permeabilization of 
the bacterial outer membrane that enhances the intracellular 
antimicrobial activity of Ag NP.[136] Conversely, as in the case 
of carbon NP and cathelicidin LL-37, NM may alter the AMP 
structure, thereby hampering their bactericidal effect.[137]
A number of innate immune cells produce intracellular 
granules that store a range of soluble factors (e.g., proteolytic 
enzymes, RNAses, peroxidases, histamine, and other media-
tors). Upon activation, these cells (eosinophils, neutrophils, 
basophils, mast cells, monocytes, and macrophages) can 
degranulate and release the active mediators in the surrounding 
tissues. Proteins such as myeloperoxidase (MPO), EPO, MBP 
(major basic protein) and ECP (eosinophil cationic protein) are 
very efficient in pathogen killing, although they can also induce 
toxicity in several tissues. MPO and EPO, mainly involved in 
bacterial and parasite clearance, were also found able to degrade 
single-walled carbon nanotubes in vitro and in vivo, a fact that 
underlines the role of leukocytes in NM clearance.[81,138] The fact 
that NM can promote NET formation, as bacteria do, further 
supports the notion that neutrophilic leukocytes are among the 
central innate effectors in NM clearance.[88,89]
Very important immune soluble factors are the cytokines, 
chemokines, and growth factors, which regulate crucial 
immune and cellular processes such as proliferation, acti-
vation, differentiation and migration. The ability of NM to 
induce an immune response is, therefore, often character-
ized by their capacity to provoke the production or secretion 
of inflammatory cytokines and chemokines. A comprehensive 
study on the capacity of engineered NM to activate in vitro the 
human monocytic cell line THP-1 to produce cytokines and 
chemokines showed that, in response to 19 different NM, there 
is little correlation between activation of innate immunity (i.e., 
production of innate cytokines and chemokines) and cytotoxic 
effects.[139] Despite the significant limitation due to the use of 
a highly proliferating tumor cell line instead of primary mono-
cytes/macrophages, an interesting result is that NM can be 
roughly grouped into those that can promote inflammation 
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(innate immune activation) and those that can apparently down-
regulate inflammation/innate immune activation by blocking 
the expression and production of inflammatory mediators. The 
induction of inflammatory mediators by NM correlates with 
the block of peroxisome proliferator-activated receptor (PPAR)/
LXR pathways. PPAR can antagonize the action of inflamma-
tory transcription factors, such as nuclear factor κB (NFκB) 
and activator protein-1 (AP-1), thereby inhibiting the produc-
tion of many inflammatory mediators and cytokines.[140] PPAR 
activation in monocytes/macrophages, obtained by targeting a 
PPAR agonist to phagocytes with a nanocarrier, achieved prom-
ising results in a preclinical model of myocardial infarction.[141] 
Modulation of PPAR activity via NM may therefore be devel-
oped as a novel therapeutic strategy for anti-inflammatory and 
pro-healing effects.
The maturation and secretion of IL-1β and IL-18, two key 
mediators of inflammation, is triggered by a cytoplasmic mul-
tiprotein complex termed the inflammasome, of which the 
NLRP3 inflammasome is the most common in monocytes and 
macrophages. Since IL-1β is a potent pyrogen that can induce 
an inflammatory form of programmed cell death (pyroptosis), 
but is also a key immune-amplifying factor in the development 
of defensive reactions, NLRP3 inflammasome activation and 
consequent production of mature IL-1β are factors that can 
either predict NM immunotoxicity or NM-mediated promo-
tion of immune defensive capacity. Abundant evidence shows 
the ability of NM to activate the NLRP3 inflammasome and 
promote the maturation of IL-1β by mechanisms that include 
ROS production, K+ efflux, lysosomal membrane destabiliza-
tion and release of cathepsin G.[62,63,65,66] The stimulation of 
monocytes or macrophages with by SiO2 and TiO2 NP could 
increase local production of adenosine, leading to an accumu-
lation of intracellular ATP that promotes/prolongs the activa-
tion of the NLRP3 inflammasome resulting in an enhanced 
release of IL-1β and IL-18.[142] It should be underlined that the 
production of IL-1β is by no means a marker of detrimental/
pathological inflammation, but only a sign of an active defen-
sive reaction. Most defensive reactions rapidly resolve, and 
only in rare cases these degenerate into chronic destructive 
anomalous inflammation (such as those observed in rheu-
matoid arthritis or multiple sclerosis). Thus, when assessing 
the possible NM immunotoxicity, the induction of an innate/
inflammatory response must be considered as a normal effect, 
while only an anomalous reaction (too prolonged in time, of 
excessive or insufficient extent) might be considered as poten-
tially harmful.
Overall, the interaction of NM with the mammalian innate 
immune system can provoke a reaction, in terms of production 
of defensive factors, which mainly results in the re-establish-
ment of tissue homeostasis. Only in rare cases were NM found 
able to provoke significantly harmful effects at the organism 
level. Conversely, the increasing body of data accumulated so 
far shows great promise for NM as agents for modulating and 
directing innate immune responses for future therapeutic appli-
cations. Table 2 summarizes the main immune pathways acti-
vated and defensive molecules produced in response to NM 
across species.
4. Nanomaterials and Global Defense 
to Infection/Damage
In all living organisms, NM represents foreign elements with 
their own physico-chemical properties, which therefore may 
interfere with the normal physiological defensive mechanisms 
of the embryos, growing organisms, and adults against infec-
tions or other challenges. From the available information, it 
appears that, at environmentally relevant concentrations, NM 
are unlikely to have a widespread detrimental effect on living 
organisms except under certain local release scenarios. How-
ever, subtle effects of NM to immune pathways resulting from 
exposures need to be understood.
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Table 2. Molecular defense responses activated by NM across species.
Organism Exposure type Innate immune gene/factor activation NM type Refs.
Plants In vitro (Tobacco BY-2 cells),  
in vivo (Arabidopsis thaliana, rice, 
corn)
Oxyradical production, gene activation (e.g., MAPK signaling, salicylic 
acid signaling, and stress response), secondary metabolite release
Ag, ZnO, Al2O3, TiO2 [91]
Earthworms In vitro (primary immune cell 
culture) and in vivo
Gene modulation (fetidin, metallothionein, coelomic cytolytic factor, and 
superoxide dismutase), lysenin release, apoptotic signaling, oxyradical 
production
TiO2
Ag
[43, 96, 104, 106]
Mussels In vitro (short-term primary 
immune cell culture) and in vivo
Oxyradical production, stress-activated MAPK signaling, apoptotic  
signaling, lysozyme release, AMP production
TiO2
SiO2
ZnO
CeO2
[14]
Sea urchins In vitro (primary immune cell 
culture) and in vivo
Gene and protein modulation (e.g., MAPK, NFκB, FGFR2, JUN, FAS, 
VEGFR, and Casp8), metabolites rewiring (e.g., pentose phosphate, 
cysteine-methionine, glycine-serine metabolism pathways),  
cytokine production
TiO2 [17, 18]
Mammals In vitro (primary immune cell 
culture) and in vivo
Hemolysis, thrombogenicity, complement activation, NFκB and oxidative 
stress signaling, production of oxyradicals, opsonins, chemotactic pep-
tides, MMP, AMP, proteolytic enzymes, RNAses, peroxidases, histamine, 
cytokines, chemokines, growth factors
Ag, Fe3O4, TiO2, ZnO, CeO2, 
Mn3O4, Au, carbon
[81, 122–124, 127, 
131–136, 138–140]
www.advancedsciencenews.com www.small-journal.com
2000598 (13 of 25) © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
In plants, several reports have addressed the activity of NM 
on plant immune defense. Field and lab studies have described 
the protective effects of different NM against a number of 
microbial plant pathogens. Protection of plant from fungal 
and bacterial diseases has been reported for several inorganic 
NP, such as ZnO, Cu, SiO2, TiO2, CaO, MgO, MnO, and Ag 
NP.[143,144] For example, ZnO NP can reduce infection by 
Fusarium graminearum, Penicillium expansum, Alternaria alter-
nata, Fusarium oxysporum, Rhizopus stolonifer, Mucor plumbeus, 
and Aspergillus flavus, as well as by phytopathogenic bacteria 
such as Pseudomonas aeruginosa.[144–147] Cu NP were more effec-
tive against Phytophthora infestans infection compared to non-
nano Cu formulations in tomato.[148,149] The best studied NM 
for protection against infections are Ag NP. Their protective 
activity is likely due to the antimicrobial effect of Ag ions. The 
same applies to Cu NP, as Cu ions are active against fungal 
phytopathogens and are widely used in bioorganic farming as 
fungicides. Cu in low doses is also essential for many plant 
processes as a micronutrient that supports the plant defensive 
mechanisms against infection. Other NM such as Zn, Ce, SiO2, 
and TiO2 NP also show suppressive effects on plant infections, 
and might also function as micronutrients. Nano formulation 
might make the elements more accessible to the plant and 
allow for lower-dose applications and potentially better uptake 
rates.[148]
In crustaceans, exposure to dietary NM enhances immune 
functions. In the freshwater prawn Macrobrachium rosenbergii 
postlarvae, improved survival, growth, total hemocyte counts 
and digestive enzyme activity were reported after exposure to 
dietary ZnO, MgO, or Cu NP.[150–152] Treatment of Pacific white 
shrimp Litopenaeus vannameinano with capsules containing the 
antioxidant lipoic acid induced positive response on immune 
parameters,[153] and Au NP exerted immunostimulatory and 
protective effects against Vibrio parahaemolyticus.[154] In the 
crab Eriocheir sinensis, dietary CeO2 NP promote growth, relieve 
ammonia nitrogen stress, and improve immune protection 
against infection with the pathogen Aeromonas hydrophila.[155]
In marine invertebrates, including bivalves, a number of 
in vivo studies have shown that, although NM at predicted 
environmental concentrations are generally not toxic, they 
may induce sub-lethal responses both at the molecular level 
and at the overall organism level. In addition to the observed 
immunomodulatory effects on circulating hemocytes, dif-
ferent NM have been shown to modulate inflammatory and 
stress responses systemically.[13,98] The overall impact on the 
physiological defense responses can be positive, as shown in 
Mytilus for certain types of CeO2 NP, which upregulate the 
expression of several immune-related genes in hemocytes, and 
exert antioxidant properties at the tissue level as in mammalian 
models.[156] Moreover, exposure of animals to TiO2 NP increases 
lysozyme and ROS production and upregulates transcription 
of AMP in hemocytes, thus resulting in increased bactericidal 
capacity of whole hemolymph.[157] On the whole, the results 
so far available on the effects of NM on innate immunity in 
bivalves indicate that, in realistic environmental exposure con-
ditions, NM are not immunotoxic but can even have a benefi-
cial effect on immune functions.
Changes in immune cell reactivity can be observed in the sea 
urchin P. lividus exposed in vivo to a range of NP (e.g., Fe3O4, 
CeO2, and SnO2), which include reduction in the production of 
the HSP70 protein, inhibition of the activity of cholinesterases 
and decrease of the basal protein levels of glucose-regulated 
protein 78.[158] These changes correlate with global toxicity, 
with animals exposed to 10−2  g L−1 of NP surviving for only 
1–2 days, while those exposed to a lower NP dose (10−4 g L−1) 
showed pathological signs (lack of spines, slow mobility) after 
5 days. On the other hand, immune cells exposed to TiO2 NP 
in vivo do not show altered HSC70 levels, and take up particles 
through a mechanism that involves the TLR4/p38 MAPK sign-
aling pathway without activating an inflammatory response.[18] 
Notably, animals exposed to TiO2 NP do not display any patho-
logical state, showing a normal locomotion capacity, regular 
movement of the spines and tube feet, characteristic adhesion 
ability, no loss of spines, no excess of excretion, no loss of ecto-
derm, and no signs of bald sea urchin disease (a bacterial infec-
tion that affects several species of sea urchins).[95]
In mammals, a recent study in mice showed that SiO2  NP 
increased mice susceptibility to P. aeruginosa. However, NP-
loaded alveolar macrophages were fully efficient in bacterial 
clearing, highlighting that particle effects are related to altera-
tions of the alveolar-capillary barrier while not affecting the 
normal course of the inflammatory responses.[159] Metal and 
metal oxide NM, including Ag and ZnO NP, are highly effec-
tive in bactericidal activity, and CuO and TiO2 NP can also 
show microbicidal capacity against various microbes including 
Klebsiella pneumoniae, Shigella dysenteriae, Vibrio cholerae, Bacillus 
subtilis, Escherichia coli, Enterococcus faecium, P. aeruginosa, and 
Staphylococcus aureus.[160] More recently, it was reported that 
vitamin C lipid NP, used to deliver antimicrobial peptide to 
macro phage lysosomes, show remarkable antimicrobial activities 
in fighting multidrug-resistant bacteria, including S. aureus and 
E. coli, even in immunocompromised septic mice.[161]
It should be noted that the vast majority of the results 
showing little toxic or immunomodulatory effects of NM was 
obtained in healthy animals or under standard cell culture con-
ditions. The possibility that NM may impact the innate immune 
defensive mechanisms of weaker, immunocompromised 
organisms, or under chronic inflammatory conditions is, there-
fore, still possible and remains under-investigated. In a murine 
model of ovalbumin (OVA)-induced lung inflammation, SiO2 
NP act as adjuvant of allergic airway inflammation, suggesting 
that they might worsen the disease in allergic individuals.[162] 
Additional studies confirmed the allergy-promoting effects of 
SiO2 NP and report similar effects for metal oxide NP. Indeed, 
the particular individual conditions play a crucial role in deter-
mining the immune reaction to NP; while in non-pregnant 
mice the allergy-promoting effect of TiO2 NP is only moderate, 
OVA-induced lung inflammation is clearly exacerbated in preg-
nant mice. This indicates that, possibly due to a pro-allergy 
reactive hormone/cytokine milieu in pregnant mice, inflamma-
tory responses to NM may be enhanced during pregnancy.[163] 
Because NM have the ability to penetrate physiological barriers 
including the placental barrier,[164] potential effects of accumu-
lating NP in embryonic tissues require attention. Many types 
of NM, including Si, Ag, and TiO2 NP, were reported having 
effects on embryonic development in fish, amphibian, bird, and 
mammalian embryos, with reduced weight, deformities and an 
increase in toxicity.[165]
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While most studies explain potential pathologic effects 
of NM by their ability to induce toxicity and inflammation, a 
growing body of evidence suggests that some NM, especially 
metal, carbon and CeO2 NP, can display immunosuppressive 
effects. This is through direct interference with inflamma-
tory signaling pathways, preventing inflammasome assembly 
or acting as radical scavengers, thereby suppressing oxidative 
stress and inflammatory responses. While potentially useful in 
suppressing excessive inflammation (e.g., in chronic inflam-
matory diseases), a potential immunosuppressive effect due to 
the NM should be considered in nanomedicine, in particular 
in nanoparticulate anticancer therapies, because the NM could 
reduce efficient antitumor responses and increase susceptibility 
to infections.[166] The multiple effects of NM and their dual 
role in inflammation and immunosuppression thus further 
increases the complexity of understanding the contribution of 
NM to immunity. Developing embryos, young immunologically 
immature animals, damaged organisms or disease-affected 
individuals (e.g., chronic inflammatory diseases, cancer, and 
autoimmunity) may all react to NM in an inadequate manner, 
failing to adapt or to respond by elimination, thereby risking 
pathological consequences.
The effects of different NM on innate immune defenses of 
living species, from plants to mammals, are summarized in 
Figure 4.
5. Nanomaterials and Interaction with Bacteria
The interaction between NM and microorganisms is signifi-
cant, and it is at the basis of an emerging discipline dubbed 
nanomicrobiology. It is notable that microorganisms naturally 
synthesize NP as a mechanism to detoxify their environment 
from toxic elements, normally heavy metals,[167] or use them as 
electrodes to assist direct interspecies electron transfer[168] or 
as reservoirs to release with molecular precision some essen-
tial elements (upon NM dissolution) at the site of action, for 
instance bactericidal ions (Ag+)[169] or pro-proliferating ones 
(Fe2+).[170] The NM size and water solubility allow them to 
finely integrate into the biological machinery. The interaction 
of prokariota with inorganic natural elements is clearly more 
intense and effective when compared to eukariota.
Regarding the interaction of NM with the immune system 
through microbiota, one has to bear in mind that the immune 
system develops upon interaction with microbiota. The 
system reaches an equilibrium in which commensal micro-
biota populate different organs and fluids of the organism 
without triggering an immune reaction, while only invading 
microorganisms induce a defensive immune response. Thus, 
NM can trigger immune responses only when they localize 
in some usually secluded tissues and present particular sur-
face patterns that can be recognized by PRR or other innate 
receptors.[171] Triggering immunity may be undesirable if the 
activation is excessive, prolonged, or inducing severe tissue 
damage, but may result into an increase of host defenses 
against potential infection. Effects can be even more basal 
because of the possible similarities between microorganisms 
and NM that mimic biological structures, since the immune 
reactivity and competence develops as a consequence of the 
interaction with microorganisms.[172]
NM may admix with microbial communities and inter-
fere with their biology, and induce population shifts and 
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Figure 4. Effect of NM on innate immune defensive functions across living species. The figure depicts the effects of different NM, listed on the left, on 
innate immune defensive functions of different living species, i.e., plants (upper right), crustaceans and other invertebrates (center right), and mam-
mals (lower right). Details are given in the text. Artwork by Paola Italiani.
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modifications in the different consortia by empowering or 
restraining different species. The possibility of shaping the 
microbiota communities with the use of NM can be used at 
our advantage, as increasing evidence indicates that our health 
status[173] and therapy response[174] are strongly dependent on 
the gut microbiota. NM can provide microbiota with different 
essential elements, from iron to magnesium and zinc, to 
ultratrace ones such as selenium, cobalt or nickel,[175] or they 
can provide a hostile environment to pathogens or undesirable 
species colonizing our gut.[176]
5.1. Host–Bacteria Interactions under Nanomaterial Exposure
A major application of NM is as an antimicrobial agent. NM 
efficacy as antimicrobial agents is thought to be linked to the 
physical interaction with the bacterial walls, followed by forma-
tion of lesions in the cell membrane and subsequent intracel-
lular accumulation of toxic ions.[177,178] Over the last decade, 
the increased availability and accessibility of high-throughput 
sequencing methods has greatly enhanced our understanding 
of the diversity and functionality of the microbial world and its 
role in animal health. The roles microbes can play in animal 
health can be diverse and include both beneficial as well as path-
ogenic interactions. Well described beneficial roles of microbes 
include the provision of nutrients,[179] aid in digestion[180] and 
degradation of complex organic molecules.[181,182] Notably, com-
mensal microbiota play an important beneficial role in immune 
defense by allowing for the adequate development of local and 
systemic immunity and by preventing the establishment of 
microbial invaders.[172] The interaction between microbes and 
host is highly dynamic, and it can switch from a beneficial or 
commensal equilibrium to a pathogenic/invasive disequilib-
rium, for example when microbes move from their original 
niche to another.[183] The immune system of animals regulates 
the host–microbe interaction at the interaction/barrier sur-
faces (e.g., in the gut), maintaining microbes that are benefi-
cial to the host and preventing invasion and barrier breaches. 
Immune recognition of microbes through PRR does not really 
distinguish between pathogenic and non-pathogenic bacteria, 
and threat is associated to the capacity of invasion (breaches of 
the barrier). This is the reason why most of the innate immune 
cells that can sense microbial patterns are located right below 
the barrier. Thus, in the case of damage of the barrier (as in 
some diseases, or mechanical or toxic) the underlying innate 
cells recognize and react also to commensal bacteria, because 
of their entry into the body. Chemical exposure can lead to dis-
turbance of the microbiota (dysbiosis),[184,185] which can nega-
tively affect host immunity, thereby promoting susceptibility to 
infections. As an example, in the tsetse fly antibiotic-induced 
loss of symbiotic bacteria severely compromises host immune 
functions making the host unable to control bacteria that are 
non-pathogenic under normal conditions.[186]
Since microbiota and immune functions are integrally 
linked, assessment of the immunosafety of NM and chemicals 
should include studies on impact on the interaction between 
bacteria and host immunity especially for those agents that are 
designed to target microbes (biocides). Studies on the impact 
of biocidal NM on host-associated microbiota are still rather 
limited in number and have been reviewed in detail else-
where.[185,187,188] Many of these studies have used rodents, and 
only a few have used nonrodent vertebrates or invertebrates as 
model species. The outcomes are somewhat contrasting with 
regards to the capacity of biocidal NM to cause disturbance to 
the host-associated microbiota. Some studies, for example, indi-
cate a clear negative effect of Ag NP on the relative abundance 
of Firmicutes and Lactobacillus,[189,190] whereas other studies 
indicate a positive or no impact of Ag NP on the relative abun-
dance of these taxa.[191–193]
The absence of clear effects of biocidal NM on the bacterial 
community structure, as reported by some,[193,194] is surprising 
given the high activity of biocidal NM in in vitro exposure studies. 
This lack of toxicity on gut microbial communities has been linked 
to physical–chemical conditions in the gastric environment. At 
low pH, as in some gastrointestinal tracts, Ag NP can quickly dis-
solve but can subsequently precipitate to form the much less toxic 
AgCl NP.[195] Intestinal anoxia is another possible driver of toxicity 
of biocidal NM. In anoxic conditions, both Cu NP and Ag NP 
can quickly sulfidize,[196–198] a reaction that strongly reduces their 
toxicity.[199–201] In addition, gut microbiota may be physically pro-
tected from exposure to biocidal NM due to their embedment into 
intestinal folds. Physical and chemical conditions in the intestine 
are thus likely modulating the toxicity of NM, as well as other 
toxicants,[184] which could explain the discrepancy in outcomes 
between in vitro and in vivo NP toxicity studies.[193]
Studies that have looked at disruption of mucosal integrity 
induced by NM have yielded contrasting results, with some 
studies showing no evidence for any histological change under 
biocidal NM exposure[192,194] and others showing strong signs of 
epithelium and crypt damage.[189] It is thus not fully understood 
under which conditions NM induce histological damage to intes-
tinal tissue. Recent studies showed that in the bivalve Mytilus gal-
loprovincialis the immunomodulatory effects of exposure to TiO2 
NP is associated with a shift in hemolymph microbial compo-
sition, indicating the interplay between the microbiota and the 
immune system.[157] Similarly, in rodents, NM-induced altera-
tions of the gut microbiota is linked to altered expression of host 
cytokines.[189,190] The co-occurring modulation by NM of the host-
associated microbiota and the host immune system, as reported 
in both invertebrates and vertebrates, thus reflects the integrated 
link between microbes and immunity, and indicates the need to 
include microbiota analysis in nano-immunosafety assessment.
5.2. Interaction of Bacterial Molecules with Nanomaterials
The effect of NM in the host–microbiota interaction is of course 
not limited to direct effects on bacterial communities or on the 
immune system. The interaction of microbial factors with NM 
can modulate immune reactions in a way that is different from 
those achieved by microbial molecules or NM separately. In a 
recent study, human DC were exposed in culture to SiO2 NP 
together with supernatants from either commensal or patho-
genic bacterial cultures.[202] In this study, NP and bacterial 
molecules together induced the production of inflammation-
related cytokines, with differences between bacterial molecules 
(those from pathogenic bacteria could induce cytokines only in 
the presence of toxic NP concentrations) and depending on the 
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NP concentration (non-pathogenic bacterial molecules could 
induce the production of different cytokines if in the presence 
of non-toxic vs toxic NP concentrations). The effect was truly 
synergistic and not due to adsorption of bacterial molecules on 
the NP surface.
It is an important issue in immunotoxicity studies the notion 
that bacterial molecules can be adsorbed on the NM surface 
giving rise to hybrid entities with new functional characteris-
tics. Of particular importance is the interaction between NM 
and bacterial endotoxins, highly inflammatory and pyrogenic 
lipopolysaccharidic molecules (i.e., LPS). Given the high abun-
dance of endotoxin in the outer membrane of Gram-negative 
bacteria, efficient recognition of endotoxin by the immune 
system is a key mechanism in host defense. Humans are par-
ticularly susceptible to LPS, which induces potent innate and 
inflammatory reactions by activating cells mainly through TLR 
receptors. It has been shown that LPS can adsorb on the sur-
face of citrate Au NP, stabilize them and reduce their ability 
to form a biocorona in human plasma.[203] LPS on the NP sur-
face is still active and can induce an inflammatory response in 
human monocytes comparable to that of free endotoxin.[203] 
Similarly, the inflammatory effect of TiO2 NP on murine mac-
rophages is significantly increased upon LPS adsorption.[204] 
Compared to free LPS, LPS absorbed on TiO2 NP induces 
similar levels of NOS, but higher expression of NOS2 pro-
teins, whereas the effect of NP in combination with unbound 
LPS is low.[204] Whether adsorption of LPS on NM increases, 
decreases or leaves unchanged the inflammatory effectiveness 
of LPS appears to strongly depend on the physical properties 
of NM, the dose and timing of administration and the target 
cell type.[205–209] We can in any case assume that LPS-coated NM 
behave differently from free LPS and uncoated NM, suggesting 
that LPS-coated NM represent new nano-objects with different 
characteristics, which will have to be considered as such in 
nanotoxicological studies.
LPS is a widespread and thermostable bacterial molecule that 
represents a ubiquitous potential source of contamination even 
in the absence of viable bacteria. Humans are highly sensitive 
to LPS and respond to 1000× lower LPS concentrations com-
pared to mice.[210,211] Careful and reliable detection of potential 
endotoxin contamination of NM is therefore crucial, especially 
in the fields of immunology, drug development, and drug 
delivery.[212,213] This also applies to NM synthesis.[214] It has been 
shown that specific components, including citrate, Triton X-100, 
and bovine serum albumin hinder reliable LPS recognition by 
commercially available LPS detection assays.[215] From these 
data, we can conclude that effects of NM on immune cells must 
be analyzed very carefully to distinguish potential contami-
nating LPS effects from real NM-mediated effects. However, 
due to their ability to interact with endotoxin and due to their 
optical and physical properties, novel LPS detection platforms 
involving NM may be developed in the future.[216]
6. Nanomaterials and Innate Memory
Immune memory is a key defensive mechanism that allows 
living organism to adapt to their environmental conditions 
by mounting efficient defense against the threatening agents 
that are present in the same environment. In plants and 
invertebrates, which do not have adaptive immunity, the term 
“immune memory” is sufficient for defining the phenomenon, 
as they display only one type of immunity, i.e., the innate defen-
sive mechanisms. On the other hand, in higher vertebrates in 
which adaptive and innate immunity coexist, the term “innate 
immune memory” specifically defines the evolutionarily con-
served memory mechanisms of innate immunity, distinct from 
the better-known adaptive immune memory. Innate memory 
enables organisms to cope in a more efficient way with external 
challenges, after a first encounter, thereby ensuring increased 
survival and fitness. How NM may induce innate memory or 
modulate the establishment of memory following the interac-
tion of organisms with foreign agents is an open question that 
needs attention, as it can have a significant long-term impact 
on the living organisms’ capacity to cope with/adapt to their 
environment.
Innate memory in plants corresponds to systemic acquired 
resistance (SAR), a phenomenon that is induced in plants by 
local pre-infection with pathogens.[217] This local infection leads 
to the activation of defense responses in the local tissue but also 
in distant uninfected tissue and is effective not only against the 
pre-infecting pathogen but to a broad spectrum of diverse path-
ogens. Such response is effective after a few hours and lasts 
for several weeks, and it primes the plant for defense to sub-
sequent infection and thereby renders the locally pre-infected 
plant resistant in all parts and against multiple pathogens.[218] 
The activation of SAR is characterized by an accumulation of 
the phytohormone SA, which acts as a signaling molecule in 
the induction of pathogenesis-related (PR) proteins. Azelaic 
acid is supposed to be a mobile signal that transports the 
priming information to distant tissues.[217]
Only very few studies concerning the role of NM on the 
induction of SAR have been conducted, and so far the mech-
anisms of these effects on the induced resistance are mostly 
unknown. Changes in the expression of A. thaliana genes 
involved in SAR after treatment with Ag NP coated with poly-
vinylpyrrolidone and silver ions (Ag+) were analyzed by Kaveh 
et al.[219] The study shows that the flagellin pattern recognition 
receptor FLS2 and the azaleic acid induced gene 1 (AZI1) are 
downregulated after NM treatment, suggesting that Ag NP 
have a negative impact on innate memory in plants.[219] The 
expression of the PR genes PR1, PR2, and PR5 was exam-
ined in A. thaliana after application of nanosized Ag–silica 
hybrid complexes and Ag NP. Genes implicated in SAR were 
significantly upregulated after treatment with NM, but the 
hybrid complexes caused a faster activation of PR genes.[220] 
Another study examined the capacity of Ag NP to induce SAR 
against tomato mosaic virus and potato virus, and their direct 
ability to suppress viral infections on tomato plants. Plants 
treated with Ag NP and later inoculated with the virus showed 
a lower disease rate. Indeed, Ag NP were able to bind virus 
particles and/or block viral replication in the case of many dif-
ferent viruses in the absence of toxicity for the host cells.[221] In 
contrast with the study described above, the expression of the 
SAR marker gene PR1 was repressed in Solanum lycopersicum 
plants treated with chitosan-polyvinyl alcohol (PVA) hydrogels 
plus copper NP (Cs-PVA + Cu NP) and Cs-PVA alone. In both 
cases the expression of PR1 was repressed in normal condition 
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but also under saline stress.[222] Imada et  al.[223] reported that 
nano-MgO treated roots rapidly generated ROS along with 
upregulation of PR1, jasmonic acid, ethylene, and systemic 
resistance-related genes.[148]
The development of nanotechnology has opened up new 
frontiers in order to solve technical problems in efficiently 
delivering plant immune inducers. In particular, mesoporous 
silica NP, already used as anticancer drug delivery systems, are 
expected to be a promising carrier of resistance inducers.[224] 
To date engineered NP have been successfully used as phyto-
hormone delivery systems[225] or like pesticide carriers in order 
to target their activity and reduce the indiscriminate leaking of 
toxic compounds, alleviating the potential adverse effects on the 
environment.[226] Functionalized mesoporous silica NP with a 
redox-responsive gatekeeper system, able to specifically release 
the resistance inducer and avoiding premature leakage in the 
delivery process, demonstrated their potential application in 
agriculture. In fact, this system has proven to be an efficient 
technique to introduce resistance inducers and reduce Phy-
tophthora infections in pineapple.[224] NM application in plants 
is still in its infancy but promising strategies are emerging. 
Therefore, some NM might in the future offer applications to 
stimulate innate immune responses in plants and help agron-
omists to reduce yield losses caused by biotic factors without 
extensive use of conventional pesticides.
Invertebrates can adapt and survive solely relying on innate 
immunity. This implies the presence of complex and sophisti-
cated mechanisms of immune specificity, and the capacity to 
mount a faster/more effective response upon re-exposure to 
threatening agents, which is the function of innate memory or 
“immune priming.” The innate memory of invertebrates is a 
well-known phenomenon, observed and exhaustively described 
in practically all phyla as consequence of infection immunity, 
natural transplantation immunity, individual, and transgenera-
tional immune priming.[227] However, molecular and functional 
immune parameters responsible of the induction of innate 
memory sensu stricto (as response to a challenge of a quies-
cent immune system that has been previously primed) remains 
largely unknown. Memory is usually induced by priming with 
infective microorganisms, and the effect is examined as survival 
to reinfection.[228–230] Notably, memory, which is based on epi-
genetic changes, can be inherited by the progeny of primed ani-
mals, thereby enhancing the fitness of the progeny in the same 
environmental challenges encountered by the parents.[228,231,232]
Despite the widespread studies on invertebrate immune 
memory, information on memory responses to NM is virtu-
ally absent. The only available data come from an unpublished 
study in bivalves. The mussel Mytilus spp. has extremely pow-
erful immune defenses to cope with different potential patho-
gens and contaminant stressors, including NM. The possibility 
that NM may participate in immune memory has been recently 
investigated in M. galloprovincialis subjected to repeated expo-
sure to nanoplastics (amino-modified polystyrene PS-NH2), by 
examining the modulation of several functional and molecular 
parameters in hemocytes and hemolymph. First exposure indi-
cates the occurrence of stress conditions in the hemocytes, 
which, however, did not result in changes in the overall bac-
tericidal activity (suggesting a reaction that resolves without 
consequences). After second exposure, it was possible to 
observe a shift in granular hemocyte subpopulations, together 
with re-establishment of basal functional parameters and of 
proliferation/apoptotic markers. Moreover, the hemolymph 
bactericidal activity was increased, as well as transcription of 
immune related genes coding for secreted proteins. The results 
indicate both tolerance and potentiation as compensatory 
mechanisms to maintain immune homeostasis after a second 
encounter with PS-NH2, representing a form of immune 
memory.[233]
The same forms of innate memory, “tolerance” and “trained 
immunity/potentiation,” are documented in mammals/ver-
tebrates. Although the innate memory can be induced by any 
type of exposure, most of our knowledge on the tolerance 
phenomenon comes from study on LPS exposure, while that 
on trained immunity/potentiation is mainly related to expo-
sure to Bacillus Calmette–Guérin (BCG) or to fungal cell wall 
β-glucans. The concept of innate memory in higher vertebrates, 
known for decades, has recently experienced renewed interest, 
with a wealth of studies describing the effect of “priming,” 
either in vivo or in vitro, on the subsequent reactivity of innate 
immune cells (especially macrophages and monocytes) to an 
unrelated challenge. A typical experiment on the induction of 
human innate memory in vitro showed that human mono-
cytes primed with β-glucan from Candida albicans developed 
an enhanced inflammatory cytokine production after restimu-
lation with TLR1/2 agonists.[234] The molecular mechanisms 
underlying the development of innate memory in mammals 
include metabolic changes (i.e., shift from oxidative phospho-
rylation to aerobic glycolysis—“Warburg Effect)” and epige-
netic reprogramming (e.g., DNA hypermethylation and histone 
modi fications). Human monocytes and macrophages primed 
with LPS or β-glucan present specific histone modifications,[234] 
and β-glucans from C. albicans induce a metabolic reprogram-
ming of human macrophages toward aerobic glycolysis that is 
possibly involved in the development of innate memory.[235] The 
interplay between cellular metabolism and chromatin remod-
eling associated with the development of innate memory has 
been reviewed elsewhere.[236,237]
Older evidence of the existence of the innate memory in 
humans in vivo comes from epidemiological studies showing 
that vaccination with Mycobacterium bovis BCG (a live attenuated 
tuberculosis vaccine) provides protection against non-related 
infections.[238,239] A recent study highlighted the effect of BCG 
vaccination on the development of the innate memory both in 
vivo and in vitro. The authors observed that BCG vaccination 
protects humans from viral challenges (simulated with the 
administration of Yellow Fever Vaccine in volunteers) through 
the involvement of IL-1β production, and confirm in vitro the 
role of IL-1β in inducing epigenetic reprogramming of mono-
cytes.[240] The BCG-induced memory was shown to persists one 
year after vaccination.[241] This prolonged persistence of BCG-
induced memory is hard to explain because of the shorter life-
span of the innate immune cells that develop memory following 
priming (mostly monocytes and macrophages). To explain the 
persistence of innate memory, recent evidence shows that BCG 
can access the bone marrow and change the transcriptional 
landscape (i.e., the areas of chromatin accessibility) of hemat-
opoietic stem cells (HSCs) and multipotent progenitors, leading 
to local cell expansion and enhanced myelopoiesis.[242,243] The 
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authors demonstrate that BCG-educated HSC generate epige-
netically modified macrophages able to protect mice against 
virulent Mycobacterium tuberculosis infection, and that BCG-
induced HSC reprogramming occurs in vivo.
Despite the growing number of studies on innate immune 
memory in mammals/humans, and the large body of litera-
ture on the interaction of NM with the mammalian innate 
immune system,[62] NM effects on the development or mod-
ulation of the innate memory to date remains practically 
unstudied. The hypothesis that NM may have an effect on 
innate immune memory is possible and supported by a series 
of considerations arising from the fact that NM can have an 
effect on the molecular mechanisms underlying the develop-
ment of innate memory,[244] which are mainly based on epi-
genetic and metabolic reprogramming. Indeed, NM are able 
to induce both epigenetic[245] and metabolic changes.[246] Thus, 
it is reasonable to presume that NM may be able to induce or 
modulate innate memory and, therefore, affect the capacity of 
innate cells to react to a second exposure. Indeed, preliminary 
studies on human primary monocytes in vitro showed that 
exposure to Au NP could change the subsequent response to 
LPS and that changes could differ in different individuals.[244] 
Another study has proven the significant effect of Au NP in 
reducing the BCG-induced memory in human primary mono-
cytes.[247] Overall, the putative capacity of NM to interact with 
innate immune processes at the level of innate memory has 
very interesting implications, opening the way to the med-
ical use of NM for controlling subsequent innate/inflamma-
tory responses for a significant period of time, with benefi-
cial effects in autoimmunity, infections and immune-related 
diseases.
A schematic depiction of the mechanisms of innate memory 
and of the effects of NM on its establishment and effects is pro-
vided in Figure 5.
7. Conclusions and Future Challenges
When assessing the immunosafety of NM, we mainly need 
to examine the interaction of exogenous NM with the innate 
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Figure 5. Innate immune memory across living species. Upper panels: main mechanisms and effects of innate immune memory in plants, inverte-
brates, and vertebrates. Lower panels: effects of NM on the innate immune memory mechanisms in plants, invertebrates, and vertebrates. SA, salycilic 
acid; AzA, azaleic acid; FLS2, flagellin pattern recognition receptor; AZl1, azaleic acid induced gene 1; PR, pathogenesis-related. See text for detailed 
description. Artwork by Paola Italiani.
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immune system of living organisms. Innate immunity is, for 
over 95% of living eukaryotic organisms, from plants to mam-
mals, the only type of immunity displayed. This fact makes 
adaptive immunity (coexisting with innate immunity in higher 
vertebrates) a less relevant actor in the nano-immune interac-
tion. Indeed, innate immunity is the first, most powerful, and 
fastest line of immune defense. The mechanisms of innate 
immunity are fundamentally similar across species and evo-
lution, despite the fact that they are to some extent the result 
of parallel and challenge-specific evolution and that there are 
species- and environment-specific differences. Natural and 
anthropogenic NM are one of the many foreign challenges 
present in the environment that come in contact with living 
organisms and their immune system. For NM as for all foreign 
agents, based on sensing and sorting molecules and mecha-
nisms, the immune system decides the best way to cope with 
them with the ultimate goal of preserving the organism’s health 
and fitness. There are essentially three ways to cope with NM. 
Ignoring them (e.g., in marine filter feeders, they are largely 
expelled with water), adapting to them (e.g., taking and elimi-
nating/storing them with non-inflammatory non self-damaging 
mechanisms), or reacting to them with an active innate/inflam-
matory reaction. We should consider as immunosafe those NM 
that fall in each of the three cases, including those that trigger 
an innate/inflammatory reaction. Only when such reactions 
turn out to be anomalous (too prolonged in time or too short/
inefficient, excessive or too weak), then they could cause patho-
logical consequences. A summary view of the innate immune 
mechanisms engaged in the interaction with NM is presented 
in Figure 6, which underlines the similarities across species.
In light of the above considerations, we should re-think 
immuno-nanosafety by critically examining the validity and 
predictivity of the data produced by the scientific community, 
and by identifying the future challenges and most promising 
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Figure 6. Common immune mechanisms induced by NM across living species. Schematic depiction of the common mechanisms of immune reaction 
of living species (plants, green silhouette; invertebrates, purple silhouette; vertebrates, yellow silhouette). Upon interaction with the microenvironment, 
biomolecules adsorb to the NM surface and create a “biomolecular corona.” NM–biomolecule interactions signal for non-inflammatory clearance 
(opsonization and endocytosis) or trigger a defensive innate/inflammatory response through an expanded repertoire of PRR initiating an appropriate 
signaling cascade. Immune responses include ROS, MAPK activation, defense gene induction, and production of cytokines, chemokines, and growth 
factors. The combination of a multitude of cellular effects have, as result, the preservation of cell/tissue integrity and function. Artwork by Andi Alijagic.
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avenues. One of the drawbacks for understanding relevant 
effects is the use of high concentrations of NM in experimental 
settings that do not represent real life situations. Cell death 
in vitro upon exposure to high concentrations of NM may 
not reflect toxicity for the same cells in vivo within a complex 
organism and at realistic concentrations. Also, experimental 
studies still suffer of many limitations that hamper their 
reliability and that may not provide useful information. For 
instance, studies on human innate reactivity to NM are usu-
ally restricted to in vitro systems that, however complex they 
may be, still cannot reproduce the in vivo situation. The use of 
tumor cell lines instead of primary cells further decreases the 
possibility that the results obtained may be valid for normal 
cells. In addition, studies of chronic exposure are not fea-
sible with in vitro models. In vivo experimentation in rodents 
is also not ideal because of a number of significant differ-
ences, including the geometry of exposure (for instance how 
inhaled NM will deposit in the lungs of animals based on gait) 
and some critical innate immune mechanisms (e.g., comple-
ment). Therefore, one of the future challenges for human 
nano-immunosafety is that of identifying reliable experimental 
models that could realistically represent the in vivo immune 
reactions to NM and the true risk for health. Stepping from 
short-term to long-term exposure models will be a particular 
challenge. An interesting approach is to focus on invertebrates 
and plants, in which the global response to NM exposure can 
be assessed much more easily and over a long time, although 
even among invertebrates we should identify representative 
and predictive models.
Another challenge that we will have to face in assessing 
nano-immunosafety is the fact that different cells can have 
different sensitivity to NM challenge. Indeed, as mentioned 
before, some highly proliferating cells can be more suscep-
tible to chemicals or other compounds, while quiescent cells 
can be more resistant. In the context of a particular organ (e.g., 
the lung) some cells can die while others are untouched, but 
what counts is the final outcome, i.e., how the organ succeeds 
in eliminating the foreign potentially dangerous agents and re-
establishing the organ physical and functional integrity. This 
means that the susceptibility or resistance to toxicity of one 
single cell type may not reflect the events in real life conditions. 
Notably, the reaction in one organ may be limited spatially to 
that organ (or part of the organ, or some cells within the organ), 
without affecting survival or fitness.
The immunosafety of NM should also consider the pre-
existing or ongoing health conditions of the organisms. Plants 
or animals that are infected or damaged or senescent can 
be less able to adequately react to new challenges. Thus, in 
human nano-immunosafety, the effects of NM that are harm-
less in healthy conditions can still be potentially harmful in 
immunologically frail conditions. As health in invertebrates 
and vertebrates also depends on the composition of the 
associated microbiota, an additional very important area of 
investigation will be the NM–microbiota interaction, and the 
health-related consequences of such interaction for the whole 
organism.
Finally, a very interesting new area of investigation in 
nano-immunosafety is the possible effect of NM in shaping 
innate memory, i.e., in determining changes in the protective 
immune response to subsequent challenges. Immune 
memory is the mechanism by which organisms “remember” 
previous exposure to foreign agents, so that they respond 
better (with a more effective immune response) to recurring 
challenges. While the phenomenon of innate memory is well 
known in plants, invertebrates, and also in vertebrates, very 
little is known on the possibility that NM may alter the estab-
lishment of protective memory or even induce an anomalous 
memory. This is an area that needs addressing, as NM that 
have no direct effect and are therefore considered immunosafe 
could nevertheless modify immune memory with unpredict-
able consequences.
As we have summarized in this review, examining the 
interaction of NM with the innate immune defensive mecha-
nisms in plants and animals leads to the overall feeling that 
NM in general do not pose significant threats to the organ-
isms’ survival and fitness, as they rarely induce direct effects 
or interfere with ongoing innate reactions under realistic con-
ditions. Thus, it seems that the major immune responses to 
NM is silent elimination (adaptation) or successful immune 
elimination (innate/inflammatory reaction with full resolu-
tion). Of course, it is not possible to generalize, and caution 
should always be taken, and the new challenges opened by 
the advancements in our knowledge and technology should be 
confronted. Some of them, already discussed above, are listed 
hereafter:
1) Realistic and predictive experimental models.
2) Organ/tissue restriction of NM immune effects.
3) NM effects in immunologically frail organisms.
4) NM effects on organism-associated microbiota.
5) NM effects on innate immune memory.
Overall, we should aim at defining NM immunosafety not in 
absolute terms, but relative to specific conditions of use/expo-
sure (organism, tissue/organ, exposure features, health condi-
tions). While the “safe-by-design” concept seems unfeasible, we 
can successfully target a “safer-by-design” nanotechnology.
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